Literature DB >> 25658554

Predicting carriage with extended-spectrum beta-lactamase-producing bacteria at hospital admission: a cross-sectional study.

T N Platteel1, M A Leverstein-van Hall2, J W Cohen Stuart3, S F T Thijsen4, E M Mascini5, B C van Hees6, J Scharringa7, A C Fluit7, M J M Bonten7.   

Abstract

The prevalence of patients colonized with extended-spectrum beta-lactamase (ESBL)-producing bacteria increases, especially in long-term-care facilities (LTCFs). Identification of ESBL carriers at hospital admission is relevant for infection control measures and antibiotic therapy for nosocomial infections. We aimed to develop a prediction rule for ESBL carriage at hospital admission for patients admitted from home and LTCFs, and to quantify incidences of nosocomial infections caused by ESBL-producing bacteria. The ESBL-carrier status was determined of patients admitted from LTCFs and from home settings in four hospitals in the Netherlands using perianal swabs obtained within 48 hours of admission. Risk factors for ESBL carriage were assessed. Infections caused by ESBL-producing bacteria were identified retrospectively. Among 1351 patients, 111 (8.2%) were ESBL carriers at admission: 50/579 (8.6%) admitted from LTCFs and 61/772 (7.9%) from home settings (p 0.63). Previous ESBL carriage and previous hospital admission were risk factors for ESBL carriage in multivariable analysis. The area under the curve of the receiver operating characteristic curve of the model was 0.64 (95% CI 0.58-0.71). Presence of ≥1 risk factor (n = 803; 59%) had sensitivity of 72%. Incidences of nosocomial infections caused by ESBL-producing bacteria were 45.5/10,000 and 2.1/10,000 admission days for ESBL carriers and non-carriers, respectively (p <0.05). In conclusion, prevalence of ESBL carriage at hospital admission was 8.2%, and was comparable among patients admitted from LTCF and home. A clinically useful prediction rule for ESBL carriage at admission could not be developed. The absolute incidence of nosocomial infections by ESBL-producing bacteria was low, but higher among patients carrying ESBL-producing bacteria at the time of hospital admission.
Copyright © 2014 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Carriage; ESBL; Enterobacteriaceae; hospital admission; risk factors

Mesh:

Substances:

Year:  2014        PMID: 25658554     DOI: 10.1016/j.cmi.2014.09.014

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  16 in total

1.  Intestinal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae at admission in a Portuguese hospital.

Authors:  Marta Aires-de-Sousa; Elizeth Lopes; Maria Luísa Gonçalves; Ana Luísa Pereira; Augusto Machado E Costa; Hermínia de Lencastre; Laurent Poirel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-12-24       Impact factor: 3.267

2.  In 2035, will all bacteria be multidrug-resistant? No.

Authors:  François Barbier; Jeffrey Lipman; Marc J M Bonten
Journal:  Intensive Care Med       Date:  2016-04-18       Impact factor: 17.440

3.  The Role of Nursing Homes in the Spread of Antimicrobial Resistance Over the Healthcare Network.

Authors:  Carline van den Dool; Anja Haenen; Tjalling Leenstra; Jacco Wallinga
Journal:  Infect Control Hosp Epidemiol       Date:  2016-04-07       Impact factor: 3.254

4.  Travel to Asia is a strong predictor for carriage of cephalosporin resistant E. coli and Klebsiella spp. but does not explain everything; prevalence study at a Norwegian hospital 2014-2016.

Authors:  Laura Espenhain; Silje Bakken Jørgensen; Truls Michael Leegaard; Michaela Marie Lelek; Siri Haug Hänsgen; Britt Nakstad; Marianne Sunde; Martin Steinbakk
Journal:  Antimicrob Resist Infect Control       Date:  2018-11-29       Impact factor: 4.887

5.  Admission prevalence of colonization with third-generation cephalosporin-resistant Enterobacteriaceae and subsequent infection rates in a German university hospital.

Authors:  Anne-Cathérine Boldt; Frank Schwab; Anna M Rohde; Axel Kola; Minh Trang Bui; Nayana Märtin; Marina Kipnis; Christin Schröder; Rasmus Leistner; Miriam Wiese-Posselt; Janine Zweigner; Petra Gastmeier; Luisa A Denkel
Journal:  PLoS One       Date:  2018-08-01       Impact factor: 3.240

6.  Local prevalence of extended-spectrum beta-lactamase (ESBL) producing Enterobacteriaceae intestinal carriers at admission and co-expression of ESBL and OXA-48 carbapenemase in Klebsiella pneumoniae: a prevalence survey in a Spanish University Hospital.

Authors:  Cristina Díaz-Agero Pérez; Nieves López-Fresneña; Angela L Rincon Carlavilla; Marta Hernandez Garcia; Patricia Ruiz-Garbajosa; Jesús María Aranaz-Andrés; Friederike Maechler; Petra Gastmeier; Marc J M Bonten; Rafael Canton
Journal:  BMJ Open       Date:  2019-03-01       Impact factor: 2.692

7.  High prevalence of multidrug resistant Enterobacteriaceae among residents of long term care facilities in Amsterdam, the Netherlands.

Authors:  Eline van Dulm; Aletta T R Tholen; Annika Pettersson; Martijn S van Rooijen; Ina Willemsen; Peter Molenaar; Marjolein Damen; Paul Gruteke; Paul Oostvogel; Ed J Kuijper; Cees M P M Hertogh; Christina M J E Vandenbroucke-Grauls; Maarten Scholing
Journal:  PLoS One       Date:  2019-09-12       Impact factor: 3.240

8.  Independent, external validation of clinical prediction rules for the identification of extended-spectrum β-lactamase-producing Enterobacterales, University Hospital Basel, Switzerland, January 2010 to December 2016.

Authors:  Isabelle Vock; Lisandra Aguilar-Bultet; Adrian Egli; Pranita D Tamma; Sarah Tschudin-Sutter
Journal:  Euro Surveill       Date:  2020-07

9.  Prevalence of faecal carriage of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli in veterinary hospital staff and students.

Authors:  Alexandra Royden; Emma Ormandy; Gina Pinchbeck; Ben Pascoe; Matthew D Hitchings; Samuel K Sheppard; Nicola J Williams
Journal:  Vet Rec Open       Date:  2019-01-07

10.  Association between rectal colonization with Highly Resistant Gram-negative Rods (HR-GNRs) and subsequent infection with HR-GNRs in clinical patients: A one year historical cohort study.

Authors:  Dennis Souverein; Sjoerd M Euser; Bjorn L Herpers; Jan Kluytmans; John W A Rossen; Jeroen W Den Boer
Journal:  PLoS One       Date:  2019-01-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.